Increased PD-L1 expression on tumor cells was noted on BRCA-1 mutated cancers only, and this difference may be related to an increased frequency of loss of PTEN function in BRCA-1 as compared to BRCA-2 [28]. The gene discussed is CD274; the disease is neoplasm.